These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 27575712)

  • 1. Gallstones and the Risk of Gallbladder Cancer Mortality: A Cohort Study.
    Ryu S; Chang Y; Yun KE; Jung HS; Shin JH; Shin H
    Am J Gastroenterol; 2016 Oct; 111(10):1476-1487. PubMed ID: 27575712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma.
    Nordenstedt H; Mattsson F; El-Serag H; Lagergren J
    Br J Cancer; 2012 Feb; 106(5):1011-5. PubMed ID: 22240785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database.
    Kim BW; Oh CM; Choi HY; Park JW; Cho H; Ki M
    Gut Liver; 2019 Jan; 13(1):104-113. PubMed ID: 29938462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.
    Nagino M; Kamiya J; Nishio H; Ebata T; Arai T; Nimura Y
    Ann Surg; 2006 Mar; 243(3):364-72. PubMed ID: 16495702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort.
    Liao SF; Koshiol J; Huang YH; Jackson SS; Huang YH; Chan C; Huang C; Liu PC; Chen YJ; Hsieh RJ; Huang CP; Lu SN; Chen CJ; Shen CY; Lee MH
    Hepatology; 2021 Oct; 74(4):1994-2006. PubMed ID: 33942350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
    Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
    World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.
    Itoh H; Nishijima K; Kurosaka Y; Takegawa S; Kiriyama M; Dohba S; Kojima Y; Saitoh Y
    Dig Dis Sci; 2005 Dec; 50(12):2231-42. PubMed ID: 16416167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies.
    McGee EE; Jackson SS; Petrick JL; Van Dyke AL; Adami HO; Albanes D; Andreotti G; Beane-Freeman LE; Berrington de Gonzalez A; Buring JE; Chan AT; Chen Y; Fraser GE; Freedman ND; Gao YT; Gapstur SM; Gaziano JM; Giles GG; Grant EJ; Grodstein F; Hartge P; Jenab M; Kitahara CM; Knutsen SF; Koh WP; Larsson SC; Lee IM; Liao LM; Luo J; Milne RL; Monroe KR; Neuhouser ML; O'Brien KM; Peters U; Poynter JN; Purdue MP; Robien K; Sandler DP; Sawada N; Schairer C; Sesso HD; Simon TG; Sinha R; Stolzenberg-Solomon R; Tsugane S; Wang R; Weiderpass E; Weinstein SJ; White E; Wolk A; Yuan JM; Zeleniuch-Jacquotte A; Zhang X; Zhu B; McGlynn KA; Campbell PT; Koshiol J
    J Natl Cancer Inst; 2019 Dec; 111(12):1263-1278. PubMed ID: 31127946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC).
    Ji JH; Song HN; Kim RB; Oh SY; Lim HY; Park JO; Park SH; Kim MJ; Lee SI; Ryou SH; Hwang IG; Jang JS; Kim HJ; Choi JY; Kang JH
    Jpn J Clin Oncol; 2015 Mar; 45(3):256-60. PubMed ID: 25628352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas.
    Chow WH; Johansen C; Gridley G; Mellemkjaer L; Olsen JH; Fraumeni JF
    Br J Cancer; 1999 Feb; 79(3-4):640-4. PubMed ID: 10027343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystectomy reduces the risk of cholangiocarcinoma in patients with complicated gallstones, but has negligible effect on hepatocellular carcinoma.
    Ahn HS; Kim HJ; Kang TU; Park SM
    J Gastroenterol Hepatol; 2022 Apr; 37(4):669-677. PubMed ID: 34907591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
    Patt YZ; Hassan MM; Aguayo A; Nooka AK; Lozano RD; Curley SA; Vauthey JN; Ellis LM; Schnirer II; Wolff RA; Charnsangavej C; Brown TD
    Cancer; 2004 Aug; 101(3):578-86. PubMed ID: 15274071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallstones, Cholecystectomy and the Risk of Hepatobiliary and Pancreatic Cancer: A Nationwide Population-based Cohort Study in Korea.
    Huang D; Lee J; Song N; Cho S; Choe S; Shin A
    J Cancer Prev; 2020 Sep; 25(3):164-172. PubMed ID: 33033710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the gallbladder and extrahepatic biliary ducts in Rochester, Minnesota, 1935--1971.
    Maram ES; Ludwig J; Kurland LT; Brian DD
    Am J Epidemiol; 1979 Feb; 109(2):152-7. PubMed ID: 425954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prediction Rule for Risk Stratification of Incidentally Discovered Gallstones: Results From a Large Cohort Study.
    Shabanzadeh DM; Sørensen LT; Jørgensen T
    Gastroenterology; 2016 Jan; 150(1):156-167.e1. PubMed ID: 26375367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.
    Kamal H; Sadr-Azodi O; Engstrand L; Brusselaers N
    Hepatology; 2021 Oct; 74(4):2021-2031. PubMed ID: 34018229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China.
    Hsing AW; Bai Y; Andreotti G; Rashid A; Deng J; Chen J; Goldstein AM; Han TQ; Shen MC; Fraumeni JF; Gao YT
    Int J Cancer; 2007 Aug; 121(4):832-8. PubMed ID: 17450525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.